124 related articles for article (PubMed ID: 9214441)
1. Antibodies to beta2-glycoprotein I in patients with systemic lupus erythematosus: comment on the articles by Tsutsumi et al and Roubey et al.
Inanç M; Isenberg DA
Arthritis Rheum; 1997 Jul; 40(7):1366-8. PubMed ID: 9214441
[No Abstract] [Full Text] [Related]
2. Anti-beta 2-glycoprotein I antibodies and thrombosis.
Viard JP; Amoura Z; Bach JF
Clin Rev Allergy Immunol; 1995; 13(1):67-72. PubMed ID: 7648351
[No Abstract] [Full Text] [Related]
3. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
Borodin AG; Baranov NG; Nasonov EL
Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
5. Anti-beta 2-glycoprotein I antibody testing in patients with antiphospholipid syndrome.
Cabral AR; Alarcón-Segovia D
Br J Rheumatol; 1997 Nov; 36(11):1235. PubMed ID: 9402876
[No Abstract] [Full Text] [Related]
6. Anticardiolipin antibodies and beta 2-glycoprotein I.
Koike T; Matsuura E
Lupus; 1996 Apr; 5(2):156-7. PubMed ID: 8743131
[No Abstract] [Full Text] [Related]
7. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
[TBL] [Abstract][Full Text] [Related]
8. The concomitant presence of lupus anticoagulant, anticardiolipin and anti-beta2-glycoprotein i antibodies could be associated with acquired activated protein c resistance in non-systemic lupus erythematosus patients.
Gennari L; Blanco A; Alberto MF; Grosso S; Lazzari MA
Br J Haematol; 2003 May; 121(3):527-9. PubMed ID: 12716380
[No Abstract] [Full Text] [Related]
9. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
10. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
11. [Thrombosis in collagen diseases--diversity of serum autoantibodies in antiphospholipid syndrome].
Kaburagi J
Rinsho Ketsueki; 2002 Jun; 43(6):454-8. PubMed ID: 12134700
[No Abstract] [Full Text] [Related]
12. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
13. Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus.
Takeda I; Iwadate H; Sugisaki K; Takahashi A; Nogae S; Kanno T; Kasukawa R
Fukushima J Med Sci; 2005 Jun; 51(1):11-8. PubMed ID: 16167669
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta2 glycoprotein 1 and the anti-phospholipid syndrome.
Keane PA; Ravikumar K; O'shea SI; Cleary PE
Am J Ophthalmol; 2006 Oct; 142(4):701-2. PubMed ID: 17011877
[TBL] [Abstract][Full Text] [Related]
15. Accelerated atheroma and anti-beta2-glycoprotein I antibodies.
Matsuura E; Koike T
Lupus; 2000; 9(3):210-6. PubMed ID: 10805490
[No Abstract] [Full Text] [Related]
16. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
17. Binding of high-avidity anti-beta2-glycoprotein I antibodies.
Cucnik S; Kveder T; Rozman B; Bozic B
Rheumatology (Oxford); 2004 Nov; 43(11):1353-6. PubMed ID: 15280573
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome.
Alves JD; Ames PR
Immunobiology; 2003; 207(1):23-8. PubMed ID: 12638899
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Lupus; 1995 Dec; 4(6):472-6. PubMed ID: 8749570
[TBL] [Abstract][Full Text] [Related]
20. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen.
Arvieux J; Roussel B; Jacob MC; Colomb MG
J Immunol Methods; 1991 Oct; 143(2):223-9. PubMed ID: 1940391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
